CHANG, HSUEH WEI,张学伟,張學偉,CHANG, HSUN SHUO,张训硕,張訓碩,HUANG, MING YII,黄旼仪,黃旼儀,TANG, JEN YANG,汤人仰,湯人仰,CHEN, IH SHENG,陈益昇,陳益昇
申请号：
TW105127395
公开号：
TWI577376B
申请日:
2016.08.26
申请国别(地区):
TW
年份:
2017
代理人:
摘要：
The present disclosure provides a pharmaceutical composition for treating oral cancer, including: an effect amount of a compound of Formula (I) shown as follows: wherein R1 is selected form a group consisting of hydrogen, hydroxyl, methoxyl, methyl, formyl and formic acid R2 is hydrogen, hydroxyl or methoxyl R3 is hydrogen, hydroxyl or methoxyl R4 is hydrogen, hydroxyl or methoxyl, and wherein the compound of Formula (I) has an effect of selectively killing oral cancer cells and a pharmaceutically acceptable carrier or salt.本發明提供一種用於治療口腔癌之醫藥組成物,包括:一有效量之如以下式(I)所示之化合物為活性成分:其中,R1係擇自由以下所構成之群組:氫基、氫氧基、甲氧基、甲烷基、甲醛基與甲酸基;R2為氫基、氫氧基或甲氧基;R3為氫基、氫氧基或甲氧基;R4為氫基、氫氧基或甲氧基,且其中該式(I)所示之化合物具有選擇性殺死口腔癌細胞之功效;以及一藥學上可接受之載體或鹽類。
